TheraRadar
Company Portfolios →

Ono Pharmaceutical Co. Ltd

35 active trials across 9 therapeutic areas

35
Active Trials
15
Phase 1
15
Phase 2
5
Phase 3
9
Therapeutic Areas
Portfolio Concentration: 66% of active trials in Oncology

Oncology

23 active / 36 total
Non-Hodgkin Lymphoma
6 active 1 Ph3
6 total since 2015
Solid Tumor (Advanced)
3 active
7 total since 2015
Colorectal Cancer
3 active
3 total since 2015
NSCLC
2 active
5 total since 2015
Gastric Cancer
2 active 1 Ph3
4 total since 2015
Pancreatic Cancer
2 active
3 total since 2015
Hematologic Malignancies
1 active
2 total since 2015
Breast Cancer
1 active
1 total since 2015
HER2- Breast Cancer
1 active
1 total since 2015
CLL
1 active
1 total since 2015
Hodgkin Lymphoma
1 active
1 total since 2015
MDS
0 active
1 total since 2015
Esophageal Cancer
0 active
1 total since 2015

CNS

6 active / 7 total
Alzheimer's Disease
2 active
2 total since 2015
Anxiety
1 active
1 total since 2015
Major Depression
1 active
1 total since 2015
Epilepsy
1 active 1 Ph3
1 total since 2015
Multiple Sclerosis
1 active
1 total since 2015
Neuropathy
0 active
1 total since 2015

Immunology

1 active / 3 total
Rheumatoid Arthritis
1 active
2 total since 2015
Psoriasis
0 active
1 total since 2015

Pain

1 active / 2 total
Neuropathic Pain
1 active
1 total since 2015
Acute Pain
0 active
1 total since 2015

Cardiovascular

1 active / 2 total
Myocardial Infarction
1 active 1 Ph3
1 total since 2015
Thrombosis
0 active
1 total since 2015

Urology

0 active / 2 total
Erectile Dysfunction
0 active
1 total since 2015
Overactive Bladder
0 active
1 total since 2015

Endocrine

0 active / 2 total
Acromegaly
0 active
2 total since 2015

Musculoskeletal

0 active / 2 total
Osteoarthritis
0 active
2 total since 2015

Infectious Disease

0 active / 1 total
COVID-19
0 active
1 total since 2015

Click an indication to see competitive landscape (all sponsors in that indication).

Data: ClinicalTrials.gov (2015+)